At one point, it was Europe’s most valuable company.
Now, as Danish pharmaceutical group Novo Nordisk prepares to publish its third-quarter earnings on Wednesday, the picture looks very different.
Jonathan Raa | Nurphoto | Getty Images
CNBC’s Charlotte Reed will travel to Copenhagen to speak with the company’s new CEO Mark Doustdar, a 30-year veteran of the company, who has been in the top job since August.
It’s not been an easy ride so far, with the group announcing a sharp decline in sales, pressure on profit, a round of jobs cuts and continued competition from U.S. rivals when it comes to the blockbuster obesity drug market.
Analysts’ views
Despite this, Berenberg is positive on the stock, saying Novo has hit “peak uncertainty.”
“Novo’s superior growth profile and best-in-class R&D returns warrants a higher valuation premium to its peers,” the bank added.
Other analysts are less forgiving.
Jefferies recently cut the stock’s rating to underperform, citing competitive pressure in the U.S. and pricing concerns. Meanwhile, UBS analysts are concerned Novo’s 8 billion Danish krone ($1.23 billion) one-off cost related to its restructuring has not been fully reflected on the bottom line, while adding that investors are continuing to question the group’s lack of consumer experience in the American market.
On Oct. 17, U.S. President Donald Trump told a press conference that the price of Novo’s blockbuster weight-loss drug Ozempic would be “much lower” as part of the administration’s negotiations over pricing with the company.
The share price has been under pressure since the start of the year.
Tough year for Novo Nordisk shares
Boardroom meltdown
Earnings releases this week:
Monday: Ryanair, Berkshire Hathaway
Tuesday: BP, Philips, Ferrari, Uber, Pfizer
Wednesday: Novo Nordisk, BMW, Orsted, ARM, McDonald’s
Autumn is entering the home straight. Winter is coming. We are more than due, therefore, a piece of fantasy/folkloric tomfoolery set in the days of yore – which is further back than yesteryear and therefore more forgiving all round – stuffed…
Why, hello there! Perhaps you’re here for another helping of conveniently digestible reading material to peruse over your weekend cornflakes? In that case, pull up a chair and settle in as we head for darker corners. This…
The Top 10 of today’s Spotify Global Top 50 looks like business as usual: two Taylor Swift songs; Lady Gaga and Bruno Mars’ Die With a Smile hanging around for an eighth month; the eminently normal male pop stars Sombr and Alex Warren doing…
“As far as I am aware, I am the only person in the world to undergo a kidney transplant, and then become professional and then qualify for the Mr Olympia competition in America,” he said.
“For the last few years I always felt like I could do it…
EDMONTON, AB – Evan Bouchard scored 2:43 into overtime, and Head Coach Kris Knoblauch earned his 100th career NHL victory on Saturday as the Edmonton Oilers came away with a 3-2 win over the Chicago Blackhawks to close out their three-game…
Quite a few insiders have dramatically grown their holdings in Oakley Capital Investments Limited (LON:OCI) over the past 12 months. An insider’s optimism about the company’s prospects is a positive sign.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
In the last twelve months, the biggest single purchase by an insider was when Co-Founder Peter Adam Dubens bought UK£579k worth of shares at a price of UK£5.06 per share. That means that an insider was happy to buy shares at around the current price of UK£5.60. That means they have been optimistic about the company in the past, though they may have changed their mind. While we always like to see insider buying, it’s less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. In this case we’re pleased to report that the insider purchases were made at close to current prices.
Oakley Capital Investments insiders may have bought shares in the last year, but they didn’t sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
See our latest analysis for Oakley Capital Investments
LSE:OCI Insider Trading Volume November 2nd 2025
Oakley Capital Investments is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Over the last quarter, Oakley Capital Investments insiders have spent a meaningful amount on shares. Not only was there no selling that we can see, but they collectively bought UK£77k worth of shares. This makes one think the business has some good points.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it’s a good sign if insiders own a significant number of shares in the company. It’s great to see that Oakley Capital Investments insiders own 13% of the company, worth about UK£124m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
It is good to see recent purchasing. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Oakley Capital Investments. That’s what I like to see! In addition to knowing about insider transactions going on, it’s beneficial to identify the risks facing Oakley Capital Investments. To assist with this, we’ve discovered 1 warning sign that you should run your eye over to get a better picture of Oakley Capital Investments.
If you would prefer to check out another company — one with potentially superior financials — then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
